In a research report released Friday, Rodman & Renshaw analyst Amit Dayal reiterated a Buy rating on shares of Second Sight Medical Products Inc (NASDAQ:EYES), …
by Sonya Colberg Two eye-opening announcements over the last couple of days jumped shares of Second Sight Medical Products Inc (NASDAQ:EYES) above $6 …
Second Sight Medical Products Inc (NASDAQ:EYES), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, announced …
Second Sight Medical Products Inc (NASDAQ:EYES), a developer, manufacturer and marketer of implantable visual prosthetics to restore some useful vision to blind patients, today …
Second Sight Medical Products Inc (NASDAQ:EYES), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, …
Second Sight Medical Products Inc (NASDAQ:EYES), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today …
In a research report released Wednesday, Rodman & Renshaw analyst Amit Dayal reiterated a Buy rating on Second Sight Medical Products Inc (NASDAQ:EYES) with …
Second Sight Medical Products Inc (NASDAQ:EYES), a developer, manufacturer and marketer of implantable visual prosthetics that restore some useful vision to blind patients, today …
